The global Catheter Market is estimated to be valued at USD 12,746.2 million in 2025 and is projected to reach USD 23,260.9 million by 2035, registering a compound annual growth rate of 6.1% over the forecast period.
| Metric | Value |
|---|---|
| Industry Size (2025E) | USD 12,746.2 million |
| Industry Value (2035F) | USD 23,260.9 million |
| CAGR | 6.1% |
The catheter market, represents around 3.8% of the global medical devices market, underscoring its role as a foundational segment within interventional and therapeutic procedures. Catheters contribute about 18% of the Cardiovascular Devices Market, reflecting their central use in angiography, cardiac ablation, and electrophysiology. Additionally, the category accounts for nearly 22% of the Drug Delivery Devices Market, driven by widespread adoption of central venous catheters and peripherally inserted central catheters (PICCs) for oncology and chronic therapies.
Within the Nephrology Devices Market, catheters hold a share of approximately 15%, primarily through hemodialysis and peritoneal dialysis access systems. This positioning highlights the catheter segment’s multi-disciplinary relevance and steady demand, both in acute care and long-term disease management.
The market has experienced an expansion, supported by increasing procedural volumes in critical care, chronic disease management, and minimally invasive interventions. Hospitals and ambulatory surgical centers have prioritized catheter utilization for drug delivery, hemodynamic monitoring, and drainage procedures as part of standardized treatment protocols. Advances in materials science have driven the development of biocompatible, antimicrobial, and hydrophilic-coated catheters, which have improved safety profiles and reduced infection risk.
Regulatory guidelines and accreditation standards have emphasized best practices for catheter insertion and maintenance, reinforcing clinician training and supply chain investments. Technological innovation in catheter tip design, lumen configuration, and securement solutions has further optimized performance and workflow efficiency.
Intravenous Catheters is estimated to contribute a revenue share of 64.7% has been attributed to intravenous catheters, highlighting their pivotal role across hospital and outpatient settings. The segment is driven by their broad application in fluid administration, parenteral nutrition, chemotherapy, and emergency interventions.
Advances in catheter material composition, such as polyurethane and silicone, have improved biocompatibility and reduced the incidence of phlebitis and infection. Clinical protocols have standardized IV catheter placement as an essential component of care for surgical, critical, and oncology patients. Manufacturers have invested in safety-engineered designs, including closed IV systems and integrated needle protection, to comply with occupational safety regulations and reduce needle stick injuries.
Drug Deliver accounts for 52.6% revenue share, reflecting the core function of catheters in modern healthcare delivery. Utilization has been driven by the need for precise, reliable, and continuous administration of medications ranging from antibiotics to chemotherapy agents. Hospitals and cancer research institutes and Infusion Centers have adopted vascular access devices, including peripherally inserted central catheters (PICCs) and implantable ports, to support long-term infusion therapy.
Advances in catheter lumen design and anti-reflux valves have improved dosing accuracy and reduced complications. These dynamics have established drug delivery as the leading application segment, with continued growth expected as chronic disease treatment and home infusion therapy expand globally.
Hospitals have accounted for 47.1% of market revenue, driven by their role as primary providers of acute care and complex medical interventions. The segment dominance is supported by centralized procurement processes and integrated inventory management systems that ensure consistent availability of catheters for inpatient care.
Clinical protocols have mandated catheter use for surgical recovery, emergency interventions, and critical care monitoring. Hospitals have prioritized staff training and adherence to infection prevention guidelines to minimize catheter-associated complications. Investment in infrastructure and patient safety initiatives has further strengthened hospital utilization, positioning this segment for sustained growth as procedural volumes rise.
Several stakeholders in the field participated in a questionnaire and were asked about their thoughts and viewpoints regarding the performance of the catheter industry during a short survey by Future Market Insights.
Based on these objectives, the data results had a broad consensus that the advanced catheter materials, especially silicone and antimicrobial-coated, reduced infections and improved patient comfort, leading to their increasing adoption.
Participants highlighted the increasing demand for minimally invasive procedures, prompting advancements in catheter design and functionality.
Furthermore, common themes included the importance of regulatory compliance and stringent quality standards as determinants of product development and industry entry.
The other important insight from the survey was the growing investment in research and development for their technological advancements for catheter durability and performance. Industry leaders cited the need for catheters with greater flexibility, biocompatibility, and longevity, particularly for long-term use in chronic disease management.
Stakeholders categorized the emerging industry as major growth regions as healthcare infrastructure and the accessibility of advanced medical technologies have improved in regions such as Asia-Pacific and Latin America.
| Country/Region | Regulatory Impact and Mandatory Certifications |
|---|---|
| European Union (EU) | Medical device manufacturers must comply with the Medical Device Regulation (MDR), ensuring stringent safety and performance standards. Certification under ISO 13485 is essential for quality management. |
| United Kingdom (UK) | The UK enforces its own Medical Device Regulation post-Brexit, requiring compliance with UK MDR. ISO 13485 remains the recognized quality standard for medical devices. |
| United States (USA) | The FDA regulates medical devices under the Quality System Regulation (QSR). Efforts are ongoing to align these standards with ISO 13485 to streamline approvals. |
| Canada | Medical devices must meet the Canadian Medical Device Regulations and obtain ISO 13485 certification, ensuring compliance with quality and safety requirements. |
| India | The CDSCO oversees regulatory approvals for medical devices, making certification mandatory. The Bureau of Indian Standards (BIS) sets additional quality requirements for specific medical products. |
| Japan | Manufacturers must comply with ISO 13485 alongside national quality control standards outlined by the Ministry of Health, Labour and Welfare. |
The United States catheter landscape is expected to be highly profitable in the review period. It held a global share of around 35% in 2025. The country will likely register a CAGR of 6.5% during the forecast period.
Some of the key drivers of this strong growth include high prevalence of chronic urological conditions such as aggressive prostate cancer, urinary incontinence, and bladder dysfunction.
More serious one is that the aging population has greatly contributed to this, as the elderly need a greater long-term catheterization to combat these problems.
The USA also has a high volume of surgical patients in a wide range of disciplines, such as urology, gynecology, and oncology, where effective management of urinary function cannot be achieved without the use of Foley catheters.
The catheter industry in the UK is expected to grow at a CAGR of 5.8% from 2025 to 2035. As the population ages and chronic diseases such as cardiovascular diseases and diabetes become more common, catheterization becomes a more common procedure in interventional anatomical cardiovascular procedures.
In the UK, the National Health Service (NHS) distributes catheters to patients, facilitating distribution at low or no cost. Investments in technologies like antimicrobial coatings and hydrophilic-coated catheters have enhanced patient convenience while minimizing the risk of infection, driving further growth of the industry.
The industry is projected to experience robust growth due to the presence of some key manufacturers and a well-established healthcare infrastructure.
The growth of the catheter market in France is attributed to factors such as a growing geriatric population, rising prevalence of chronic urological diseases, and increasing healthcare investments.
France catheter industry is anticipated to have a CAGR of around 5.9% during the forecast period. An increase in life expectancy also expands the demand for sophisticated medical devices that address age-related conditions such as urinary incontinence, kidney disorders, and cardiovascular diseases.
The increased focus on minimally invasive procedures further boosts the utilization of catheter solutions globally in hospitals, clinics, and home healthcare settings. The latest development in catheter technology that provides major advances in the French catheter sector is the launch of innovative catheters, for example, pre-lubricated and antimicrobial-coated catheters.
Such innovations minimize the risk of infection, improve the comfort of patients, and streamline medical procedures.
Germany’s catheter industry is anticipated to have a CAGR of around 6.0% during the forecast period. Germany, as the largest healthcare industry in Europe, also boasts a robust healthcare infrastructure and a large geriatric population, which creates a rising demand for a multitude of catheter devices such as urinary, cardiovascular, and neurovascular catheters. German companies develop and produce high-quality, high-performance catheters according to international standards.
Advancements, including silver-coated and hydrophilic catheters, strives to minimize infection risks while enhancing patient outcomes. It is also located strategically in Europe with efficient distribution towards neighbouring countries, boosting its industry.
These products must comply with stringent EU medical device regulations, ensuring that they are reliable and safe, which in turn strengthens Germany's foothold in the global catheter industry.
Italy is likely to lead the catheter landscape by exhibiting a CAGR of 5.7% from 2025 to 2035. The growing population and the larger number of people suffering from chronic illnesses, such as cardiovascular disease and diabetes, the need for catheterization increases.
Advanced catheter technologies also are adopted in the Italian healthcare system, such as antimicrobial coatings and improved materials that can ensure greater comfort for patients along with less risk of infection.
The segment growth is also supported by government initiatives to enhance healthcare infrastructure and access to medical devices. There are also a few international companies working with local manufacturers to supply high-quality catheter products in Italy.
South Korea is expected to lead the catheter segment by exhibiting a CAGR of 6.8% from 2025 to 2035. The adoption of innovative catheter technologies in the country is influenced by its developed healthcare infrastructure and emphasis on technological innovation.
The demand for catheters for diagnosis and treatment is being supported by the geriatric demographic and the rise in prevalence of chronic diseases such as cardiovascular disorders and diabetes.
Manufacturers in South Korea are working on developing catheters with enhanced biocompatibility and that lead to infection rates that are lower. Also, government initiatives in support of medical device innovation and favourable reimbursement policies further fuel industry growth.
Japan has an aging population and, consequently, a high prevalence of chronic diseases that require catheterization, including urinary incontinence and cardiovascular diseases.
Similarly, Japan's commitment to technological advancement has resulted in high-grade catheters featuring antimicrobial coatings and advanced materials. The increased focus on patient safety and comfort in the healthcare system stimulates the uptake of these sophisticated products.
The partnerships among local and foreign manufacturers increase the number and range of catheter products available in the Japanese industry.
China's catheter industry is projected to grow at a strong CAGR of 5.5% from 2025 to 2035. In 2025, it accounted for approximately 9.7% of the global industry share. The tremendous industry growth is attributed to a large and aged population, the rising prevalence of chronic diseases, and advancements in healthcare infrastructure.
This is due to rising demand for catheters and other medical devices, as the Chinese government is working on providing access to quality healthcare. Domestic manufacturers are adopting advanced technologies at a rapid pace to manufacture cost-effective and high-quality catheters for both domestic and international industry.
In addition, government policies, including tax incentives, subsidies for medical device manufacturers, and increased investments in healthcare infrastructure, make the industry attractive for growth.
The country will likely register a CAGR of 6.2% during the forecast period. These countries have well-established healthcare systems and a greying population that are collectively driving up demand for catheterization procedures.
Including catheters assists in effective management of chronic diseases like diabetes and cardiovascular diseases. Industry growth is driven by the advancement of technologies and the minimization of procedures. Government initiatives further support the catheter industry's growth in these regions to improve healthcare services and accessibility to medical devices.
The catheter industry in India is expected to grow at a CAGR of around 8.5% from 2025 to 2035, driven by increasing cases of chronic diseases like diabetes and cardiovascular disorders.
A growing elderly population and improved healthcare infrastructure in rural and urban areas are also key factors fuelling demand. India’s rise as a medical tourism hub has further boosted industry expansion, with hospitals adopting advanced catheter technologies to meet international standards.
Domestic manufacturers are also focusing on cost-effective solutions, supported by the ‘Make in India’ initiative, which reduces reliance on imports and promotes local production. Overall, India's catheter industry is set for strong growth, backed by government policies, increasing healthcare investments, and rising demand for affordable, high-quality medical devices.
The catheter industry is a part of the medical devices industry and is segmented into healthcare consumables and disposables. It is an essential part of the overall healthcare system, affecting both hospitals and home health care.
Due to its critical role in efficiently in delivering cares to patient demand for catheters is relatively inelastic, making it a defensive industry that is less sensitive to economic pullbacks than discretionary sectors.
Demand for catheters is linked to global healthcare expenditure, demographic trends, and technology. The aging population in developed economies such as the USA, Japan, and Western Europe is creating strong demand due to elderly patients being more susceptible to chronic illness requiring catheterization.
At the same time, increasing middle-class incomes in the fast-growing economies of India and China are making healthcare more widely available, driving catheter usage.
Government policies regarding insurance coverage and its scope are also some of the most influential factors that drive the industry growth. There is a good reimbursement system for catheters in Europe, so we can talk about a steady demand in the EU, unlike the USA, where the entire healthcare system is still private, and, there are always new price wars.
In countries with privatized healthcare, cost and reimbursement policies may influence adoption rates. The industry also faces cost pressures from fluctuations in raw materials, inflation, and supply chain disruptions. To stay profitable, businesses are investing in increased automation, environmentally friendly alternatives, and digital integration.
The catheter landscape has significant growth potential, particularly in developing economies such as India, China, and Southeast Asia, where there is a growing investment in healthcare expenditure and the enhancement of medical infrastructure to improve services.
Local manufacturing within the country will enable companies to increase their presence in the segment, along with reducing production costs and import restrictions. Furthermore, the rising prevalence of chronic diseases such as cardiovascular disease, urinary incontinence, and neurological disorders is driving the demand for advanced catheters.
In addition, the rise of aging populations all around the world is leading to a push for home healthcare, which creates opportunities for the development of user-friendly, self-insertable catheters, making uniquely flexible catheters even more convenient for patients.
The investment in biocompatible materials and innovations focused on sustainability can give companies a competitive edge. Regulatory compliance is crucial due to increasingly stringent policies from the FDA, EU MDR, and Asian authorities.
Firms are advised to proactively obtain their CE Mark and ISO 13485 certifications. Smart technology integration and remote patient monitoring are transforming the industry. Product companies are incorporating smart technology into their devices and work with telemedicine providers for remote patient monitoring, which can drive up product sales.
Automation and localized sourcing will improve cost efficiencies and help companies stay competitive in this evolving industry.
The competitive landscape has been shaped by companies developing antimicrobial-coated catheters, integrated securement solutions, and closed-system designs to reduce infection risk and improve patient safety. Leading manufacturers have prioritized partnerships with hospitals and outpatient clinics to deliver training and ensure product adoption.
Strategic acquisitions have expanded portfolios into emerging catheter technologies such as midlines and power-injectable devices. Digital engagement and clinician education programs have been launched to drive differentiation. These activities are expected to sustain competition and foster continued innovation as demand for catheter-based therapies increases worldwide.
Key Development:
Rising chronic diseases, aging populations, and advancements in minimally invasive procedures are key drivers.
Boston Scientific, Medtronic, Coloplast, and BD are among the top players focusing on innovation.
Regulations like EU MDR and FDA guidelines ensure safety but can affect pricing and approval timelines.
Antimicrobial coatings, hydrophilic surfaces, and sensor-enabled designs enhance safety and comfort.
North America and Europe lead, while Asia-Pacific, especially China and India, is growing rapidly.
Explore Similar Insights
Catheter Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
